Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer

Fig. 3

Probability of PFS and OS in correlation with expression of KLK5 mRNA in primary tumor tissue samples of patients afflicted with advanced HGSOC stage FIGO III/IV. Patients showing high expression of KLK5 mRNA display a significantly worse PFS (Kaplan-Meier analysis, p = 0.041) (a) but not OS (b), compared to patients with low KLK5 mRNA expression levels

Back to article page